- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Janssen Vaccines & Prevention B.V.
Total 58 results
-
Janssen Vaccines & Prevention B.V.TerminatedRespiratory Syncytial Virus-associated Lower Respiratory Tract Disease PreventionUnited States
-
Janssen Vaccines & Prevention B.V.CompletedCOVID-19 PreventionUnited States, South Africa, Brazil
-
Janssen Vaccines & Prevention B.V.CompletedCoronavirus Disease-2019 (COVID-19) PreventionSouth Africa, Brazil, Argentina, Mexico, India
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus PreventionUnited States
-
Janssen Vaccines & Prevention B.V.CompletedInfluenza, Human Prevention | Respiratory Syncytial Viruses PreventionUnited States
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Terminated
-
Janssen Vaccines & Prevention B.V.CompletedHuman Immunodeficiency VirusThailand
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Active, not recruitingHealthyUnited States, Rwanda, Kenya
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial VirusCanada, United Kingdom, Spain, Brazil, Sweden, Poland, Australia, Finland
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus PreventionUnited States
-
Janssen Vaccines & Prevention B.V.CompletedA Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy AdultsCOVID-19 PreventionUnited States, Germany, Brazil, Poland, South Africa
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Tract Diseases | Respiratory Syncytial VirusesUnited States
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Viruses | Lower Respiratory Tract DiseaseUnited States, Taiwan, Thailand, Canada, Poland, United Kingdom, Brazil, Chile, New Zealand, Estonia, Finland, South Africa, Australia, China
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Janssen Vaccines & Prevention B.V.CompletedCOVID-19 PreventionUnited States, Belgium, Poland
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus Infection PreventionGermany, Spain, Belgium, Sweden, United States
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited States, Mexico, Spain, Puerto Rico, Italy, Poland, Argentina, Brazil, Peru
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Tract Infections | Respiratory Syncytial VirusesUnited Kingdom, Finland, United States
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited Kingdom, Germany, Spain, Netherlands
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Bavarian NordicTerminatedHuman Papillomavirus InfectionsUnited States, Belgium
-
Janssen Vaccines & Prevention B.V.Bavarian Nordic GmbHTerminatedHemorrhagic Fever, EbolaFrance, United Kingdom, Kenya, United States, Uganda, Burkina Faso, Tanzania
-
Janssen Vaccines & Prevention B.V.Biomedical Advanced Research and Development AuthorityActive, not recruitingInfluenza PreventionUnited States
-
Janssen Vaccines & Prevention B.V.Walter Reed Army Institute of Research (WRAIR)CompletedHemorrhagic Fever, EbolaUnited States, Uganda, Kenya, Mozambique, Nigeria, Tanzania
-
Janssen Vaccines & Prevention B.V.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
London School of Hygiene and Tropical MedicineUniversity of Sierra Leone; Janssen Vaccines & Prevention B.V.Active, not recruitingInfections | RNA Virus Infections | Virus Diseases | Mononegavirales Infections | Hemorrhagic Fevers, Viral | Hemorrhagic Fever, Ebola | Filoviridae Infections | Physiological Effects of Drugs | Vaccines | Ebola | Immunologic FactorsSierra Leone
-
Janssen Vaccines & Prevention B.V.Emory University; Coalition for Epidemic Preparedness Innovations; Center for...Completed
-
Janssen Vaccines & Prevention B.V.Institut National de la Santé Et de la Recherche Médicale, France; University...CompletedEbola Viral DiseaseFrance, United Kingdom
-
Janssen Vaccines & Prevention B.V.National Institute of Allergy and Infectious Diseases (NIAID); Beth Israel... and other collaboratorsCompletedHealthyUnited States, South Africa, Thailand, Uganda, Rwanda
-
Henry M. Jackson Foundation for the Advancement...US Military HIV Research Program; Janssen Vaccines & Prevention B.V.Not yet recruiting
-
Janssen Vaccines & Prevention B.V.Institut National de la Santé Et de la Recherche Médicale, France; Centre Muraz and other collaboratorsCompletedHemorrhagic Fever, EbolaKenya, Uganda, Burkina Faso, Côte D'Ivoire
-
Janssen Vaccines & Prevention B.V.Beth Israel Deaconess Medical Center; US Military HIV Research Program; Ragon...CompletedHuman Immunodeficiency VirusUnited States
-
Centers for Disease Control and PreventionKenya Medical Research Institute; MCM Vaccines B.V.; Kenya Ministry of HealthUnknownInfluenza | Severe Acute Respiratory Illness | Influenza Like IllnessKenya